Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Critical illness can lead to long-lasting physical and psychological problems, requiring ongoing, specialized care and rehabilitation.

Patients who survive critical illness often face long-lasting physical, mental, and cognitive issues, with many unable to return to work within a year.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Insulin resistance linked to obesity may increase COVID-19 severity.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Finasteride helps reduce lung inflammation and damage after trauma and infection.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Many women with HIV in the North of England are diagnosed late and have other health conditions.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.